Study tracks anemia drug in kidney patients not on dialysis

NCT ID NCT02567188

Completed Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study observed how well the drug MIRCERA worked to control anemia in people with moderate-to-severe kidney disease who were not yet on dialysis. Researchers followed 144 patients in their normal clinical care for up to a year to see if the drug safely kept their hemoglobin (a measure of red blood cells) in a healthy range. The goal was to understand the real-world effectiveness of this treatment for managing anemia in this patient group.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Study site

Angeholm, S-262 81, Sweden
Study site

Bollnäs, 821 81, Sweden
Study site

Eskilstuna, 63188, Sweden
Study site

Gävle, 80187, Sweden
Study site

Gothenburg, 41345, Sweden
Study site

Gothenburg, S-402 76, Sweden
Study site

Huddinge, 14186, Sweden
Study site

Jönköping, 55185, Sweden
Study site

Karlshamn, S-374 80, Sweden
Study site

Karlstad, 65185, Sweden
Study site

Kristianstad, 29185, Sweden
Study site

Linköping, S-581 85, Sweden
Study site

Mölndal, S-431 80, Sweden
Study site

Norrköping, 60182, Sweden
Study site

Skövde, 54185, Sweden
Study site

Stockholm, 17176, Sweden
Study site

Stockholm, 18288, Sweden
Study site

Umeå, 90185, Sweden
Study site

Värnamo, 33185, Sweden
Study site

Västervik, 59381, Sweden

Conditions

Explore the condition pages connected to this study.

ANEMIA